NCT02964078 2026-02-10
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
H. Lee Moffitt Cancer Center and Research Institute
AstraZeneca
Pfizer
University of Alabama at Birmingham
University of Waterloo